She added that some of the medications and dosages including oral semaglutide, dulaglutide, 0.6 mg liraglutide and 1 mg and 2 mg injectable semaglutide have not yet been approved by the FDA for the treatment of obesity and are more likely to have been prescribed for diabetes management. Perspective Back to Top A huge population was studied (413,000) that compared the effects of different weight loss medications
However, once your GLP-1 therapy is personalized through genetic insights, your PlexusDx provider can assess whether NAD aligns with your specific metabolic profile and goals
Maintenance of Weight Loss : Many patients are able to maintain their weight loss with continued use of GLP-1 medications, though lifestyle changes (diet, exercise) remain essential for long-term success
Remember that weight management is a long-term endeavour, and temporary setbacks do not negate previous progress
Impossible to tell which intervention is causing which side effect